Cheson B - Search Results

1

Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia.

Kantarjian HM, Talpaz M, Smith TL, Cortes J, Giles FJ, Rios MB, Mallard S, Gajewski J, Murgo A, Cheson B, O'Brien S. Kantarjian HM, et al. Among authors: cheson b. J Clin Oncol. 2000 Oct 15;18(20):3513-21. doi: 10.1200/JCO.2000.18.20.3513. J Clin Oncol. 2000. PMID: 11032593 Clinical Trial.

2

Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia.

O'Brien S, Kantarjian H, Koller C, Feldman E, Beran M, Andreeff M, Giralt S, Cheson B, Keating M, Freireich E, Rios MB, Talpaz M. O'Brien S, et al. Among authors: cheson b. Blood. 1999 Jun 15;93(12):4149-53. Blood. 1999. PMID: 10361112 Free article.

3

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia.

Vey N, Kantarjian H, Tran H, Beran M, O'Brien S, Bivins C, Giles F, Cortes J, Cheson B, Arbuck S, Estey E. Vey N, et al. Among authors: cheson b. Ann Oncol. 1999 May;10(5):577-83. doi: 10.1023/a:1026406920321. Ann Oncol. 1999. PMID: 10416008 Free article. Clinical Trial.

4

Homoharringtonine: history, current research, and future direction.

Kantarjian HM, Talpaz M, Santini V, Murgo A, Cheson B, O'Brien SM. Kantarjian HM, et al. Among authors: cheson b. Cancer. 2001 Sep 15;92(6):1591-605. doi: 10.1002/1097-0142(20010915)92:6<1591::aid-cncr1485>3.0.co;2-u. Cancer. 2001. PMID: 11745238 Review.

5

Expanding our mission: Clinical Lymphoma, Myeloma & Leukemia.

Cheson BD, Cortés JE, Jagannath S. Cheson BD, et al. Clin Lymphoma Myeloma. 2009 Aug;9(4):266. doi: 10.3816/CLM.2009.n.054. Clin Lymphoma Myeloma. 2009. PMID: 19717375 No abstract available.

6

Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group study.

Salmon SE, Tesh D, Crowley J, Saeed S, Finley P, Milder MS, Hutchins LF, Coltman CA Jr, Bonnet JD, Cheson B, et al. Salmon SE, et al. Among authors: cheson b. J Clin Oncol. 1990 Sep;8(9):1575-84. doi: 10.1200/JCO.1990.8.9.1575. J Clin Oncol. 1990. PMID: 2131793 Clinical Trial.

7

Clinical trials referral resource. Clinical trials with pyrazoloacridine.

Murgo AJ, Cannon D, Christian MC, Cheson B, Nelson AP. Murgo AJ, et al. Among authors: cheson b. Oncology (Williston Park). 1997 Jul;11(7):991-4. Oncology (Williston Park). 1997. PMID: 9251119 No abstract available.

8

Prognostic factors with high-dose melphalan for refractory multiple myeloma.

Barlogie B, Alexanian R, Smallwood L, Cheson B, Dixon D, Dicke K, Cabanillas F. Barlogie B, et al. Among authors: cheson b. Blood. 1988 Dec;72(6):2015-9. Blood. 1988. PMID: 3196876 Free article.

9

Innovative strategies for the treatment of CLL.

Keating M, Cheson B, Gribben JG, Robertson B, Nadler L. Keating M, et al. Among authors: cheson b. Leuk Lymphoma. 1996 Oct;22 Suppl 2:53-64. doi: 10.3109/10428199609102703. Leuk Lymphoma. 1996. PMID: 9021709 Review. No abstract available.

10

Total therapy with tandem transplants for newly diagnosed multiple myeloma.

Barlogie B, Jagannath S, Desikan KR, Mattox S, Vesole D, Siegel D, Tricot G, Munshi N, Fassas A, Singhal S, Mehta J, Anaissie E, Dhodapkar D, Naucke S, Cromer J, Sawyer J, Epstein J, Spoon D, Ayers D, Cheson B, Crowley J. Barlogie B, et al. Among authors: cheson b. Blood. 1999 Jan 1;93(1):55-65. Blood. 1999. PMID: 9864146 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

650 results

Search Page

Filters